{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:51:06Z","timestamp":1787698266714,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.neurobiolaging.2004.06.003","type":"journal-article","created":{"date-parts":[[2004,9,25]],"date-time":"2004-09-25T03:13:32Z","timestamp":1096082012000},"page":"637-643","source":"Crossref","is-referenced-by-count":71,"title":["apoE isoforms and measures of anxiety in probable AD patients and Apoe\u2212\/\u2212 mice"],"prefix":"10.1016","volume":"26","author":[{"given":"Jennifer","family":"Robertson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Curley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Pfankuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Raber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0306-4522(97)00598-8","article-title":"Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse","volume":"85","author":"Anderson","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1192\/bjp.143.3.277","article-title":"Dexamethasone suppression test and serum prolactin in dementia disorders","volume":"143","author":"Balldin","year":"1983","journal-title":"Br J Psych"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib3","first-page":"93","article-title":"Factors Associated with duration of survival in Alzheimer's disease","volume":"20","author":"Barclay","year":"1985","journal-title":"Biol Psych"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.npp.1300352","article-title":"Role of H3-receptor-mediated signaling in anxiety and cognition in wild-type and Apoe\u2212\/\u2212 mice","volume":"29","author":"Bongers","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib5","first-page":"86","article-title":"The prognosis of depression in old age","volume":"20","author":"Burvill","year":"1991","journal-title":"Br J Psych"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib6","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib7","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1212\/WNL.48.5_Suppl_6.10S","article-title":"The neuropsychiatric inventory: assessing psychopathology in dementia patients","volume":"48","author":"Cummings","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.278.16.1349","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/089198870101400111","article-title":"Anxiety and Alzheimer's disease","volume":"14","author":"Feretti","year":"2001","journal-title":"J Geriatr Psychiatr Neurol"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib10","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"1997"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/geronj\/46.6.P362","article-title":"Predictors of behavioral disturbances in Alzheimer's disease","volume":"46","author":"Gilley","year":"1991","journal-title":"J Gerontol"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0006-3223(02)01334-3","article-title":"HPA axis dysregulation in mice overexpressing corticotropin releasing hormone","volume":"51","author":"Groenink","year":"2002","journal-title":"Biol Psych"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib13","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1212\/WNL.59.5.746","article-title":"Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes","volume":"59","author":"den Heyer","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/jnnp.60.6.644","article-title":"SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele","volume":"60","author":"Lehtovirta","year":"1996","journal-title":"J Neurol Neurosurg Psych"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib15","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.82.10.3251","article-title":"Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease","volume":"82","author":"Leon","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib16","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotin E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/exnr.1995.1088","article-title":"Neurodegeneration in the central nervous system of apoE-deficient mice","volume":"136","author":"Masliah","year":"1995","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease; report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Serives Task Force on Alzheimer's disease","volume":"34","author":"McKann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib19","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/brbi.1996.0012","article-title":"Differences in dexamathasone-sensitivity between lymphocytes from patiens with Alzheimer's disease and patients with multi-infarct dementia","volume":"10","author":"Nijhuis","year":"1996","journal-title":"Brain Beh Immun"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib21","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.56.8.1094","article-title":"Increased CSF cortisol in AD is a function of APOE genotype","volume":"56","author":"Peskind","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib22","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1073\/pnas.89.10.4471","article-title":"Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targetting in embryonic stem cells","volume":"89","author":"Piedrahita","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib23","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1523\/JNEUROSCI.20-05-02064.2000","article-title":"Hypothalamic-pituitary-adrenal function in Apoe\u2212\/\u2212 mice: possible role in behavioral and metabolic alterations","volume":"20","author":"Raber","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib24","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1073\/pnas.95.18.10914","article-title":"Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females","volume":"95","author":"Raber","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib25","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1523\/JNEUROSCI.22-12-05204.2002","article-title":"Androgens protect against apolipoprotein E4-induced cognitive deficits","volume":"22","author":"Raber","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/gerona\/54.7.M348","article-title":"Anxiety of Alzheimer's disease: prevalence, and comorbidity","volume":"54","author":"Teri","year":"1999","journal-title":"J Gerontol Series A\u2013Biol Sci Med Sci."},{"key":"10.1016\/j.neurobiolaging.2004.06.003_bib27","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1523\/JNEUROSCI.17-23-09375.1997","article-title":"Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear","volume":"17","author":"Walker","year":"1997","journal-title":"J Neurosci"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458004002295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458004002295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T17:20:50Z","timestamp":1549214450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458004002295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0197458004002295"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.06.003","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}